Table 3 One-way sensitivity analysis
From: An economic evaluation of intensive hypertension control in CKD patients: a cost-effectiveness study
Discount rate | Intervention | Cost (US$) | Incremental Cost (US$) | Effectiveness (QALY) | Incremental Effectiveness (QALY) | Incremental cost effectiveness ratio (US$) | Cost/effectiveness (US$) |
|---|---|---|---|---|---|---|---|
3% | Standard | 195,938.1 | - | 15.39 | - | - | 12,732.0 |
Intensive | 203,133.1 | 7,195.0 | 15.78 | 0.39 | 18,497.1 | 12,117.2 | |
7% | Standard | 101,291.2 | - | 8.90 | - | - | 11,374.8 |
Intensive | 104,023.4 | 2,732.1 | 9.06 | 0.16 | 17,269.1 | 11,477.7 |